NM_000844.4(GRM7):c.194T>A (p.Val65Glu) AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 21, 2022
Review status:
Somatic classification
of clinical impact:
None
Review status:
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
no assertion criteria provided
Record status:
current
Accession:
RCV002839252.3

Allele description [Variation Report for NM_000844.4(GRM7):c.194T>A (p.Val65Glu)]

NM_000844.4(GRM7):c.194T>A (p.Val65Glu)

Gene:
GRM7:glutamate metabotropic receptor 7 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p26.1
Genomic location:
Preferred name:
NM_000844.4(GRM7):c.194T>A (p.Val65Glu)
HGVS:
  • NC_000003.12:g.6861582T>A
  • NG_029781.1:g.5468T>A
  • NG_029781.2:g.5469T>A
  • NG_098506.1:g.445T>A
  • NM_000844.4:c.194T>AMANE SELECT
  • NM_181874.3:c.194T>A
  • NP_000835.1:p.Val65Glu
  • NP_870989.1:p.Val65Glu
  • NC_000003.11:g.6903269T>A
...more
Protein change:
V65E
Molecular consequence:
  • NM_000844.4:c.194T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_181874.3:c.194T>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003212658Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Aug 21, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Last Updated: Sep 29, 2024

External link. Please review our privacy policy.